Phibro Animal Health Stock (NASDAQ: PAHC) stock price, news, charts, stock research, profile.
Open | $13.030 |
Close | $12.870 |
Volume / Avg. | 99.784K / 141.582K |
Day Range | 12.670 - 13.050 |
52 Wk Range | 9.400 - 15.980 |
Market Cap | $521.281M |
P/E Ratio | 34.865 |
Dividend Yield | 3.720% |
Exchange | NASDAQ |
RSI | 49 |
Short Interest | 5.81% |
Days to Cover | 5.28 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Phibro Animal Health (NASDAQ: PAHC) through any online brokerage.
Other companies in Phibro Animal Health’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS) and SNDL (NASDAQ:SNDL).
The latest price target for Phibro Animal Health (NASDAQ: PAHC) was reported by Morgan Stanley on Thursday, November 9, 2023. The analyst firm set a price target for 16.00 expecting PAHC to rise to within 12 months (a possible 24.32% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Phibro Animal Health (NASDAQ: PAHC) is $12.87 last updated April 17, 2024 at 4:00 PM EDT.
A quarterly cash dividend of $0.12 per share of Class A Common Stock. The quarterly cash dividend was payable on March 27, 2024 to stockholders of record on March 5, 2024.
Phibro Animal Health’s Q3 earnings are confirmed for Wednesday, May 1, 2024.
There is no upcoming split for Phibro Animal Health.
Phibro Animal Health is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.